SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 156 filers reported holding SAREPTA THERAPEUTICS INC in Q3 2015. The put-call ratio across all filers is 0.45 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $61,952,000 | -41.4% | 2,258,531 | +31.2% | 0.01% | -50.0% |
Q3 2016 | $105,745,000 | +245.3% | 1,721,948 | +7.2% | 0.02% | +214.3% |
Q2 2016 | $30,624,000 | -5.6% | 1,605,847 | -3.4% | 0.01% | -12.5% |
Q1 2016 | $32,439,000 | -48.3% | 1,661,818 | +2.2% | 0.01% | -42.9% |
Q4 2015 | $62,710,000 | +24.4% | 1,625,447 | +3.5% | 0.01% | +7.7% |
Q3 2015 | $50,413,000 | +8.4% | 1,570,016 | +2.7% | 0.01% | +18.2% |
Q2 2015 | $46,522,000 | +124.4% | 1,528,833 | -2.1% | 0.01% | +120.0% |
Q1 2015 | $20,730,000 | -5.5% | 1,560,992 | +3.0% | 0.01% | 0.0% |
Q4 2014 | $21,932,000 | -24.8% | 1,515,691 | +9.7% | 0.01% | -37.5% |
Q3 2014 | $29,146,000 | -29.6% | 1,381,334 | -0.7% | 0.01% | -33.3% |
Q2 2014 | $41,427,000 | +22.3% | 1,390,644 | -1.3% | 0.01% | +20.0% |
Q1 2014 | $33,873,000 | +22.0% | 1,409,614 | +3.4% | 0.01% | +25.0% |
Q4 2013 | $27,767,000 | -52.1% | 1,363,153 | +11.1% | 0.01% | -60.0% |
Q3 2013 | $57,947,000 | +49.7% | 1,226,911 | +20.6% | 0.02% | +42.9% |
Q2 2013 | $38,708,000 | – | 1,017,593 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Perceptive Advisors | 2,878,979 | $69,182,000 | 7.27% |
Eventide Asset Management | 259,100 | $6,226,000 | 0.97% |
GLADE BROOK CAPITAL PARTNERS LLC | 251,000 | $6,032,000 | 0.93% |
IMS Capital Management | 32,215 | $774,000 | 0.91% |
Perceptive Advisors | 350,000 | $8,413,000 | 0.88% |
Benchmark Capital Advisors | 34,900 | $839,000 | 0.58% |
BECK CAPITAL MANAGEMENT, LLC | 24,744 | $636,000 | 0.49% |
SABBY MANAGEMENT, LLC | 352,100 | $8,461,000 | 0.47% |
Hatteras Alternative Mutual Funds, LLC | 39,404 | $947,000 | 0.46% |
Potomac Capital Management, Inc. | 22,100 | $531,000 | 0.45% |